Fralin Biomedical Research Institute at VTC COVID-19 Community Conversation
Fralin Biomedical Research Institute at VTC COVID-19 Community Conversation
Feb. 17, 2022
12:00 p.m. to 1:00 p.m.
Archived video
About the event
Scientists, physicians, public health experts, and Virginia Tech leaders discuss the ongoing and future impacts of the COVID-19 pandemic.
Moderator: Michael Friedlander, Ph.D., executive director of the Fralin Biomedical Research Institute and Virginia Tech's vice president for Health Sciences and Technology
Panelists:
- Anthony Boffoe-Bonnie, M.D., Associate Professor of Internal Medicine (infectious disease), Virginia Tech Carilion School of Medicine and Carilion Clinic
- Paige Bordwine, MPH, MT (ASCP), Southwest Regional Epidemiologist, Virginia Department of Health
- Carla Finkielstein, Ph.D., Associate Professor, Fralin Biomedical Research Institute at VTC and Department of Biological Sciences, and Scientific Director, Molecular Diagnostics Lab
- Laura Hungerford, DVM/MPH/Ph.D., Professor and Department Head, Population Health Sciences, Virginia-Maryland College of Veterinary Medicine, and Co-director, VT COVID-19 Modeling Group
- Linsey Marr, Ph.D., Charles Lunsford Professor of Civil and Environmental Engineering, Virginia Tech
- Michael Mulhare, Virginia Tech Assistant Vice President for Emergency Management
Discussant: Aimee Surprenant, Ph.D., Dean, Virginia Tech Graduate School
You May Also Be Interested In...
-
Home Item
Pathways and Regulation of Cardiac Nav1.5 Channel Trafficking in Adult Myocytes , homeMay 30, 2025, 11:00 a.m. | Gea-Ny Tseng, Ph.D., Professor, Department of Physiology and Biophysics, Virginia Commonwealth University School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Vascular and Heart Research
-
Home Item
Targeting Acquired Dependencies During Tumor Evolution , homeJune 6, 2025, 11:00 a.m. | Kris Wood, Ph.D., Associate Professor, Department of Pharmacology and Cancer Biology, Duke University School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Center – D.C.